While the Secretary of Health and Human Services Tom Price says we can expect the next Food and Drug Administrator commissioner to be named soon, significant meetings held by designated FDA policy makers with persons outside the executive branch continue to draw down.
Acting FDA Commissioner Stephen M. Ostroff has
Continue Reading Vacant positions are slowing things down at FDA and FSIS